TEST BANK FOR PHARMACOTHERAPEUTICS FOR
b
b
b b
b
b
ADVANCED PRACTICE A PRACTICAL APPROACH 5TH b b b b b
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
b b b b b b
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
b b b b b b
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
b b b b b b b b b
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
b b b b b b b b
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
b b b b b b
For more Test banks, ATI, HES! exams, and more contact us.
b b b b b b b b b b
, Tableofcontent b b
Chapter I Issues for the Practitioner in Drug Therapy
b b b b b b b b
Chapter 2 Pharmacokinetic Basis ofTherapeutics and Pharmacodynamic Principles
b b b b b b b b
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Chapter
b b b b b b b b b b b b
4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation Chapter 5
b b b b b b b b b b b
Pharmacotherapy Principles in Older Adults
b b b b b
Chapter 6 Principles of Antimicrobial Therapy Chapter
b b b b b b
7 Pharmacogenomies
b b
Chapter 8 The Economics of Pharmacotherapeutics
b b b b b
Chapter 9 Pharmacotherapy of Pain Management
b b b b b b
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
b b b b b b b b b
Chapter 11 Cannabis and Pain Management
b b b b b b
Chapter 12 Contact Dermatitis
b b b
Chapter 13 Fungal, Viral, and Bacterial Infections ofthe Skin
b b b b b b b b b
Chapter 14 Psoriasis
b b b
Chapter I5 Acne Vulgaris and Rosacea Chapter
b b b b b b
16 Ophthalmic Disorders
b b b
Chapter I7 Otitis Media and Otitis Externa
b b b b b b
Chapter I8 Hypertension
b b b
Chapter I9 Hyperlipidemia
b b
Chapter 20 Chronic Stable Angina and Myocardial Infarction
b b b b b b b
Chapter 2I Heart Failure
b b b b
Chapter 22 Arrhythmias
b b
Chapter 23 Respiratory Infections
b b b
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Chapter
b b b b b b b b
25 Gastric, Functional, and Inflammatory Bowel Disorders Chapter 26
b b b b b b b b b
Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapter 27
b b b b b b b b b
Liver Diseases
b b
Chapter 28 Urinary Tract Infection
b b b b
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chapter
b b b b b b b
30 Overactive Bladder
b b b
Chapter 3I Sexually Transmitted Infections
b b b b
Chapter 32 Osteoarthritis and Gout
b b b b b
bChapter 33 Osteoporosisb b
Chapter 34 Rheumatoid Arthritis
b b b
Chapter 35 Headaches
b b b
Chapter 36 Seizure Disorders
b b b
Chapter 37 Alzheimer's Disease
b b b b
Chapter 38 Parkinson's Disease
b b b b
Chapter 39 Major Depressive Disorder and Bipolar Disorders
b b b b b b b
Chapter 40 Anxiety Disorders
b b b b
Chapter 41 Sleep Disorders
b b b
Chapter 42 Attention Deficit Hyperactivity Disorder
b b b b b
Chapter 43 Substance Use Disorders
b b b b b
Chapter 44 Diabetes Mellitus
b b b
Chapter 45 Thyroid and Parathyroid Disorders
b b b b b
,Chapter 46 Allergies and Allergic Reactions
b b b b b
Chapter 47 Human Immunodeficiency Virus
b b b b b
Chapter 48 Organ Transplantation
b b b b
Chapter 49 Thromboembolic Disorders
b b b
Chapter 50 Anemias
b b b
Chapter 5l Immunizations
b b
Chapter 52Smoking Cessation
b b b b
Chapter 53 Weight Loss Chapter
b b b b b
54 Contraception
b b
Chapter 55 Menopause
b b
Chapter 56 Vaginitis
b b
, lOMoAR b cPSD|
b21007614
lOMoAR b cPSD| b 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
b b b b b b b b
MULTIPLE CHOICE b
1. Nurse practitioner prescriptive authority is regulated by:
b b b b b b
A. The National Council of State Boards of Nursing
b b b b b b b
B. The U.S. Drug Enforcement Administration
b b b b
C. The State Board of Nursing for each state
b b b b b b b
D. The State Board of Pharmacy
b b b b
ANS: C b PTS: 1 b
2. Physician Assistant (PA) prescriptive authority is regulated by:
b b b b b b b
A. The National Council of State Boards of Nursing
b b b b b b b
B. The U.S. Drug Enforcement Administration
b b b b
C. The State Board of Nursing
b b b b
D. The State Board of Medical Examiners
b b b b b
ANS: D b PTS: 1 b
3. Clinical judgment in prescribing includes:
b b b b
A. Factoring in the cost to the patient of the medication prescribed
b b b b b b b b b b
B. Always prescribing the newest medication available for the disease process
b b b b b b b b b
C. Handing out drug samples to poor patients b b b b b b
D. Prescribing all generic medications to cut costs b b b b b b
ANS: A b PTS: 1 b
4. Criteria for choosing an effective drug for a disorder include:
b b b b b b b b b
A. Asking the patient what drug they think would work best for them
b b b b b b b b b b b
B. Consulting nationally recognized guidelines for disease management b b b b b b
C. Prescribing medications that are available as samples before writing a prescription
b b b b b b b b b b
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
b b b b b b b
b prescribing
ANS: B b PTS: 1 b
5. Nurse practitioner practice may thrive under health-care reform due to:
b b b b b b b b b
A. The demonstrated ability of nurse practitioners to control costs and improve patient
b b b b b b b b b b b
b outcomes
B. The fact that nurse practitioners will be able to practice independently
b b b b b b b b b b
C. The fact that nurse practitioners will have full reimbursement under health-care
b b b b b b b b b b
reform
b
D. The ability to shift accountability for Medicaid to the state level
b b b b b b b b b b
ANS: A b PTS: 1 b